GCO Earnings

Quarterly EPS
$-1.79
Q2 2026
$-1.79
Q2 2026
$0.52
Q3 2026
$0.52
Q3 2026
$4.60
Q4 2026
$4.60
Q4 2026
$-1.42
Q1 2027
$0.33
Q2 2027
Latest Revenue529.9M
Latest Net Income3.5M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2027$0.33529.9M3.5M-14.0%-36.5%
Q1 2027-$1.42487.0M-14814000-21.0%-373.1%
Q4 2026$4.60799.9M47.6M+46.5%+357.0%
Q4 2026$4.60799.9M47.6M+46.5%+357.0%
Q3 2026$0.52616.2M5.4M+30.0%+125.7%
Q3 2026$0.52616.2M5.4M+30.0%+125.7%
Q2 2026-$1.79546.0M-18471000-26.8%-155.9%
Q2 2026-$1.79546.0M-18471000-8.4%-1.7%
Q1 2026-$2.02474.0M-21227000
Q1 2026-$2.02474.0M-21227000
Q4 2025$3.20745.9M34.4M
Q3 2025-$1.76596.3M-18932000
Genes (GCO) — Earnings